Stock CSL CSL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus CSL Limited

Equities

CSL

AU000000CSL8

Market Closed - Australian S.E.
Other stock markets
 07:10:45 26/04/2024 BST 		5-day change 1st Jan Change
273.3 AUD -1.85% Intraday chart for CSL Limited +1.41% -4.66%
04-26 Australian shares tumble as miners, energy stocks fall; BHP Group tanks RE
04-24 CSL Vifor and Travere Therapeutics Announces European Commission Approves FILSPARI® for the Treatment of IgA Nephropathy CI

Evolution of the average Target Price on CSL Limited

Price target over the last 5 years

History of analyst recommendation changes

1b488.pFonnlrq5p4CnuzOI7W2FwnFjSkj0cDPXB9nOuYX0H0.9y5G3zCk39Az-YWBTofFQlmKtV9Gpom_HicLCZ9FjxvJCm2vAqiC-lH5oQ~ea147ead6ba646d3df488f25865dea30

Analyst Recommendations on CSL Limited

Morgan Stanley Adjusts CSL’s Price Target to AU$310 From AU$318, Keeps at Overweight MT
Jarden Research CSL’s Price Target to AU$296.02 From AU$298.57, Keeps at Overweight MT
Jarden Research Adjusts CSL’s Price Target to AU$298.57 From AU$316.16, Keeps at Overweight MT
Australian shares post first weekly fall in three as rate-hike bets back in focus RE
Australian shares climb as slow economic growth allays rate-hike fears RE
Financials push Australian shares higher after RBA keeps cash rate steady RE
Australian shares hit 1-week high on miners' boost; Fed rate decision in focus RE
Arcturus Therapeutics Shares Rise 31% After Vaccine Collaboration DJ
Fitch Withdraws Vifor's Ratings on Acquisition by CSL AQ
Australia shares flat as miners offset CSL drag, NZ falls ahead of rates decision RE
Australia shares slump as inflation woes hint at more rate hikes RE
S&P/ASX 200 : Australian Shares Struggle for Direction Amid Mixed Earnings Results; Unemployment Rate Decreases in January MT
National Australia Bank : Australia shares wobble ahead of cenbank rate decision; NZ falls RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
178.2 USD
Average target price
199.4 USD
Spread / Average Target
+11.88%
High Price Target
220.4 USD
Spread / Highest target
+23.66%
Low Price Target
151.1 USD
Spread / Lowest Target
-15.21%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CSL Limited

Morgan Stanley
Jarden Research

Ratings for CSL Limited

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CSL Stock
  4. Consensus CSL Limited